ClinicalTrials.gg
RecruitingNCT03545477Updated Oct 15, 2026

Assessment of the Rehabilitative Effects of Curved-walking Training in Stroke, Parkinson and Orthopaedic Populations

An interventional study of Novel locomotion treatment: curved-walking training and Standard locomotion treatment: straight-walking training in Stroke, Acute, Parkinson Disease and Femur Fracture, sponsored by Istituti Clinici Scientifici Maugeri SpA. Recruiting at 1 site in Italy. Open to participants aged 18 Years to 90 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-15.

Sponsored by Istituti Clinici Scientifici Maugeri SpA · Not applicable, Interventional, and Treatment

How we know

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Jan 2018, registered Apr 2018).
  • Started Jan 2018; still recruiting 8 years 10 months later.
Updated Oct 15, 2026Now RecruitingPrimary completion moved+1 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
210
Allocation
Randomized
Ages
18 Years to 90 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 10 studies in Stroke by Istituti Clinici Scientifici Maugeri SpA — 6 open to participants now, 6 under way, none of them phase 3. Stroke · Istituti Clinici Scientifici Maugeri SpA.

Started
2018
with 2 others
No phase
8 of 10
5 open now
Registered
2nd of 10
by date

Among the 10 studies in Stroke by Istituti Clinici Scientifici Maugeri SpA, this one is one of 3 that started in 2018, is one of 8 with no phase, and was the 2nd registered.

Stroke

8,283 studies on the registry are indexed under Stroke; 2,065 are open to participants now.

Browse Stroke studies →

Open to participants now

6 of the 10 studies in Stroke by Istituti Clinici Scientifici Maugeri SpA are open now, in 1 country. Recruiting first, the newest first:

By country, each count listing its studies:

All 6 open studies →

Where they have run

Who these studies take

Of the 1,418 Stroke studies recruiting now, 698 (49%) set no upper age limit and 281 (20%) stop at 75 or younger; 77 take children under 18; 197 take healthy volunteers.

This study: 18 Years to 90 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 10 studies in Stroke by Istituti Clinici Scientifici Maugeri SpA, or all of them as a file.
02

Study summary

The recovery of walking ability is crucial to promote independence in daily living and is one of the major goal of neuromotor rehabilitation.

Currently, standard rehabilitative programs are usually based on straight-walking training (SWT) and the assessment of their effects is performed through functional scales based on straight-walking trajectories, e.g. Timed Up and Go (TUG), 10 meters walking test (10mWT).

Curved-walking training (CWT) may be interesting to provide an ecological and challenging context during rehabilitation. Indeed, CWT is based on demanding neural processes that drive an asymmetrical contribution at lower limb level, challenging balance ability and complex adaptation such as body weight shifting in response to centrifugal force and production of different step lengths.

Up to now, literature has investigated CWT in healthy adults in terms of muscular activation, kinematics and kinetics of the movement. Results showed that CWT needs a different biomechanical strategy with respect to SWT. Nevertheless CWT has not been investigated in pathological adults.

The present study aims at assessing the effectiveness of a rehabilitative physical therapy based on CWT with respect to traditional SWT for the recovery of locomotor abilities in neurological and orthopaedic patients.

The hypothesis is that a training based on curved-walking is ecologically meaningful and may be superior with respect to standard training in improving balance, walking abilities, and independence in activity of daily live of patients.

A secondary aim of the project is to propose an innovative functional scale based on the timed up and go on curved trajectory (CTUG), and to determine its reliability and responsiveness, establishing the minimum Detectable Change (MDC) and the Minimal Clinically Important Difference (MCID).

A single-blind randomized controlled study is being carried out on three different populations:

  • Post-acute stroke patients
  • Idiopathic Parkinson Disease
  • Femoral fracture

A healthy group is also being recruited to provide reference values of CTUG. For each of the three populations, subjects are randomized into two groups. The experimental one performs a novel rehabilitative program composed by a 30-minute training on curved trajectory ("S" trajectory composed by two semicircle with a radius of 1.2 m) in addition to usual care. The control group performs an equal dose of traditional treatment on straight trajectories.

Both groups undergo 20 90-minutes sessions of training (three times a week for seven weeks).

Participants are evaluated at baseline (T0), after training (T1), and at a three-months follow-up visit (T2).

The primary outcome measure is the 10mWT (minimal clinically important difference of 0.16 m/s identified by Tilson and colleagues). On the basis of this measure, a sample size of 70 subjects for each population was computed.

03

Conditions studied

  • Stroke, Acute
  • Parkinson Disease
  • Femur Fracture

Keywords

  • gait rehabilitation
  • curved walking training
  • lower limb
04

Who can participate

Ages eligible
18 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Post-acute stroke patients experiencing a stroke less than 6 months before recruitment
  • Idiopathic Parkinson Disease with disability level from moderate to severe (modified Hoehn \& Yahr scale 2.5-4)
  • Femoral fracture, less than 1 month form surgery

Exclusion criteria

Exclusion Criteria:

  • Cognitive deficits (Mini Mental Scale Evaluation \< 24)
  • Hemineglect
  • Modified Ashworth Scale of lower limb >2
  • Unstable pharmacological treatment for Parkinson's Disease during the 15 days before the recruitment
  • cardiopathic conditions
  • metabolic conditions (e.g. dialysis) that prevent patients from aerobic training
  • Previous history of major neurological, vascular, musculoskeletal disorders
  • > 30 Kg/m2
  • Invasive pharmacological treatment or surgery for Parkinson's disease
  • lower limb pain (VAS >3)
Terms in these criteria, in plain language(1)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

BMI (body mass index)

Weight in kilograms divided by height in metres squared. Example: 70 kg and 1.75 m gives 70 ÷ (1.75 × 1.75) ≈ 22.9.

What counts as overweight or obesity differs between countries (some use lower cut-offs), so go by the range the study states.

05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
210 participants (estimated)

Study arms

  • Experimental
    Novel treatment, curved-walking training

    It consists of 20 sessions of training (three times a week for seven weeks) composed by standard physical therapy and a novel approach to locomotion rehabilitation based on curved-walking training. Each session lasts about 90 minutes.

    Other: Novel locomotion treatment: curved-walking training · Other: Standard physical therapy

  • Active comparator
    Usual care

    It consists of 20 sessions of training (three times a week for seven weeks) of standard physical therapy and conventional straight-walking training. Each session lasts about 90 minutes.

    Other: Standard locomotion treatment: straight-walking training · Other: Standard physical therapy

Interventions

  • OtherNovel locomotion treatment: curved-walking training

    Each training session is comprehensive of a 30-minute walking training on curved trajectory ("S" trajectory composed by two semicircle with a radius of 1.2 m)

  • OtherStandard locomotion treatment: straight-walking training

    It consists of 30 minutes of locomotion training on straight trajectories, as typically proposed during traditional gait rehabilitation

  • OtherStandard physical therapy

    It consists of 60 minutes of stretching, muscular conditioning and coordination,postural exercises for trunk control, standing, functional exercies and upper limb rehabilitation, customized on patient's need.

06

What researchers measure

Primary outcomes

  1. Change in 10 meter walk test (10MWT)

    Time (seconds) needed by patients to walk for 10 meters

    Time frame: Baseline, 7 weeks, 20 weeks

Secondary outcomes

  1. curved-walking test

    Time (seconds) needed to complete the "S" curved trajectory (7.53 m)

    Time frame: Baseline, 7 weeks, 20 weeks

  2. Timed Up and Go (TUG)

    Time (seconds) needed to the patient to stand up upon therapist's command, walk 3 meters, turn around, walk back to the chair and sit down.

    Time frame: Baseline, 7 weeks, 20 weeks

  3. Curved Timed Up and Go

    Time (seconds) needed to the patient to stand up upon therapist's command, walk 3 meters following the curved trajectory, turn around, walk back on the curved trajectory to the chair and sit down.

    Time frame: Baseline (test), day 2 (retest), 7 weeks, 20 weeks

  4. Balance test

    Balance performance assessed by Balance test. Postural stability is evaluated using the commercial balance board Balance Master basicTM, NeuroCom® International, Inc. Assessments evaluate the postural sways during upright stance both with eyes open and closed; the limits of stability in different directions (forward, backward, right, and left); and the capability to shift the weight both left/right and forward/backward.

    Time frame: Baseline, 7 weeks, 20 weeks

  5. Pain Numerical Rating Scale

    Pain perceived on 11 levels (0-10)

    Time frame: Baseline, 7 weeks, 20 weeks

  6. Short Form Healthy Survey SF-36

    Healthy status investigated in 36 questions

    Time frame: Baseline, 7 weeks, 20 weeks

  7. Falls Efficacy Scale (FES)

    Risk of falls evaluated with 10 elements, each scored from 0 to 10. A total score higher than 70 suggests fear of falls.

    Time frame: Baseline, 7 weeks, 20 weeks

  8. Global Perceived Effect (GPE) for patients

    Perceived effectiveness of training for patients. A score from 1 (significantly improved) to 7 (significantly worsened) is assigned.

    Time frame: 7 weeks

  9. Global Perceived Effect (GPE) for physiotherapists

    Perceived effectiveness of training for physiotherapists. A score from 1 (significantly improved) to 7 (significantly worsened) is assigned.

    Time frame: 7 weeks

  10. Motricity Index (MI)

    Functional ability of limb - post-stroke population only. The quality of different limb movement are scored from 0 to 33 points, with a total score of 100 for each limb

    Time frame: Baseline, 7 weeks, 20 weeks

  11. 39-Item Parkinson's Disease Questionnaire (PDQ-39)

    Quality of life questionnaire - Parkinson's Disease only. The questionnaire is based on 39 questions and the total score ranges from 0% (no difficulty) to 100% (maximum level of difficulty)

    Time frame: Baseline, 7 weeks, 20 weeks

  12. Tampa Scale for Kinesiophobia (TSK)

    Fear of movement - Parkinson's Disease only. Score ranges from 13 (no fear) to 52 (maximum fear).

    Time frame: Baseline, 7 weeks, 20 weeks

  13. Unified parkinson's Disease Rating Scale (UPDRS)

    Parkinson's Disease prognosis information - Parkinson's Disease only. Score ranges from 0 (normal) to 199 (severe impairment).

    Time frame: Baseline, 7 weeks, 20 weeks

  14. Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC)

    Physical functionality, pain and stiffness - post-femoral fracture only. Its score ranges from 0 (high healthy status) to 100 (low healthy status)

    Time frame: Baseline, 7 weeks, 20 weeks

07

Study locations

1 of 1 sites recruiting
  • Istituti Clinici Scientifici Maugeri Spa, Scientific Institute of Lissone
    Lissone, Monza E Brianza 20851, Italy
    Recruiting
08

References and documents

Publications

  • Tilson JK, Sullivan KJ, Cen SY, Rose DK, Koradia CH, Azen SP, Duncan PW; Locomotor Experience Applied Post Stroke (LEAPS) Investigative Team. Meaningful gait speed improvement during the first 60 days poststroke: minimal clinically important difference. Phys Ther. 2010 Feb;90(2):196-208. doi: 10.2522/ptj.20090079. Epub 2009 Dec 18. PubMed 20022995 ↗
  • Courtine G, Papaxanthis C, Schieppati M. Coordinated modulation of locomotor muscle synergies constructs straight-ahead and curvilinear walking in humans. Exp Brain Res. 2006 Apr;170(3):320-35. doi: 10.1007/s00221-005-0215-7. Epub 2005 Nov 19. PubMed 16328271 ↗
  • Courtine G, Schieppati M. Human walking along a curved path. I. Body trajectory, segment orientation and the effect of vision. Eur J Neurosci. 2003 Jul;18(1):177-90. doi: 10.1046/j.1460-9568.2003.02736.x. PubMed 12859351 ↗
  • Godi M, Turcato AM, Schieppati M, Nardone A. Test-retest reliability of an insole plantar pressure system to assess gait along linear and curved trajectories. J Neuroeng Rehabil. 2014 Jun 5;11:95. doi: 10.1186/1743-0003-11-95. PubMed 24903003 ↗
09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2018 (actual). Primary completion is estimated for Jan 2028, 120 months after the start.

Of 3,121 non-industry interventional studies with no phase under Stroke, half reached primary completion within 23 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 46. This study's planned 120 months is above that.

Counting every sponsor, half of 3,265 studies reached it within 23 months; a quarter within 10 and three quarters within 46.

Since we started tracking on Sep 25, 2026, the dates moved once, on Oct 15, 2026: primary completion Jan 2023 → Jan 2028 and completion Jan 2023 → Jun 2028.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Apr 24, 2018
First posted
Jun 4, 2018
StartActual
Jan 1, 2018
Primary completionEst.
Jan 1, 2028was Jan 2023
CompletionEst.
Jun 1, 2028was Jan 2023
Last update
Oct 15, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Status unknown→Recruiting
changed Oct 15, 2026
Primary completion
Jan 1, 2023→Jan 1, 2028
Oct 15, 2026
Study completion
Jan 1, 2023→Jun 1, 2028
Oct 15, 2026
Show all 1 update
  1. Oct 15, 2026
    Status unknown→Recruiting
    Primary completion Jan 1, 2023→Jan 1, 2028
    Study completion Jan 1, 2023→Jun 1, 2028
    + 3 other changes: index terms, verification date and responsible party

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT03545477
Collaborators
Dept. of Electronics, Informatics, Bioengineering, Politecnico di Milano, Italy
Responsible party
Sponsor
First posted
Jun 4, 2018
Start date
Jan 1, 2018
Primary completion
Jan 1, 2028 (estimated)
Completion
Jun 1, 2028 (estimated)
Last update
Oct 15, 2026

Study contacts

Giorgio Ferriero
Contact
giorgio.ferriero@icsmaugeri.it
00390394657259
Giorgio Ferriero, PhD
principal investigator · Istituti Clinici Scientifici Maugeri Spa, Scientific institute of Lissone

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion